ImmunoPrecise Antibodies Ltd. filed its 40-F on Jul 10, 2023 for the period ending Apr 30, 2023. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | 0.00% | +1.59% | -25.15% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.15% | 33.68M | |
-3.35% | 88.91B | |
+4.08% | 41.25B | |
-15.13% | 31.99B | |
+50.13% | 24.73B | |
-15.28% | 15.54B | |
-40.39% | 12.07B | |
-8.63% | 12.05B | |
-14.12% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- IPA Stock
- News ImmunoPrecise Antibodies Ltd.
- ImmunoPrecise Antibodies Ltd. Auditor Raises 'Going Concern' Doubt